Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Recruiting · NCT01804634 · Registry updated 2026-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Reduced Intensity Haploidentical BMT for High Risk Solid Tumors | Ewing sarcoma, Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, connective tissue neoplasm, epithelial neoplasm, hepatoblastoma, mixed neoplasm, myomatous neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, osteosarcoma, primitive neuroectodermal tumor, rhabdomyosarcoma, sarcoma | Recruiting | Phase 2 | 2026-03-13 | NCT01804634 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 117 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Albert Einstein College of Medicine, Children's Hospital at Montefiore | The Bronx | United States | 2 |
| New York Medical Center/ Maria Fareri Children's Hospital | Valhalla | United States | 2 |
| The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | United States | 4 |